MultiplAI Health
About:
MultiplAI Health is a leveraging advances in genomics and artificial intelligence to develop universal remote screening.
Website: https://multiplaihealth.com/
Twitter/X: multiplaihealth
Top Investors: Zentynel Frontier Investments, HeartX, First In Ventures, SF500, Greater London Authority
Description:
MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superb biomarker to detect diseases earlier. Our test can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.
2.25M GBP
$1M to $10M
London, England, United Kingdom
2019-10-01
info(AT)multiplaihealth.com
Charlie Luzzani, Mark Ramondt, Santiago Miriuka
11-50
2024-09-30
Private
© 2025 bioDAO.ai